Long-term, intermittent, insulin-induced hypoglycemia produces marked obesity without hyperphagia or insulin resistance: A model for weight gain with intensive insulin therapy

Ewan C. McNay, Jennifer A Teske, Catherine M. Kotz, Ambrose Dunn-Meynell, Barry E. Levin, Rory J. McCrimmon, Robert S. Sherwin

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

A major side effect of insulin treatment of diabetes is weight gain, which limits patient compliance and may pose additional health risks. Although the mechanisms responsible for this weight gain are poorly understood, it has been suggested that there may be a link to the incidence of recurrent episodes of hypoglycemia. Here we present a rodent model of marked weight gain associated with weekly insulin-induced hypoglycemic episodes in the absence of diabetes. Insulin treatment caused a significant increase in both body weight and fat mass, accompanied by reduced motor activity, lowered thermogenesis in response to a cold challenge, and reduced brown fat uncoupling protein mRNA. However, there was no effect of insulin treatment on total food intake nor on hypothalamic neuropeptide Y or proopiomelanocortin mRNA expression, and insulin-treated animals did not become insulinresistant. Our results suggest that repeated iatrogenic hypoglycemia leads to weight gain, and that such weight gain is associated with a multifaceted deficit in metabolic regulation rather than to a chronic increase in caloric intake.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume304
Issue number2
DOIs
StatePublished - Jan 15 2013

Fingerprint

Hyperphagia
Hypoglycemia
Weight Gain
Insulin Resistance
Obesity
Insulin
Therapeutics
Pro-Opiomelanocortin
Messenger RNA
Brown Adipose Tissue
Thermogenesis
Neuropeptide Y
Patient Compliance
Energy Intake
Hypoglycemic Agents
Adipose Tissue
Rodentia
Motor Activity
Eating
Body Weight

Keywords

  • Diabetes
  • Hypoglycemia
  • Insulin
  • Obesity

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Endocrinology, Diabetes and Metabolism

Cite this

Long-term, intermittent, insulin-induced hypoglycemia produces marked obesity without hyperphagia or insulin resistance : A model for weight gain with intensive insulin therapy. / McNay, Ewan C.; Teske, Jennifer A; Kotz, Catherine M.; Dunn-Meynell, Ambrose; Levin, Barry E.; McCrimmon, Rory J.; Sherwin, Robert S.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 304, No. 2, 15.01.2013.

Research output: Contribution to journalArticle

@article{174c6505cca1419ba8be592f20309080,
title = "Long-term, intermittent, insulin-induced hypoglycemia produces marked obesity without hyperphagia or insulin resistance: A model for weight gain with intensive insulin therapy",
abstract = "A major side effect of insulin treatment of diabetes is weight gain, which limits patient compliance and may pose additional health risks. Although the mechanisms responsible for this weight gain are poorly understood, it has been suggested that there may be a link to the incidence of recurrent episodes of hypoglycemia. Here we present a rodent model of marked weight gain associated with weekly insulin-induced hypoglycemic episodes in the absence of diabetes. Insulin treatment caused a significant increase in both body weight and fat mass, accompanied by reduced motor activity, lowered thermogenesis in response to a cold challenge, and reduced brown fat uncoupling protein mRNA. However, there was no effect of insulin treatment on total food intake nor on hypothalamic neuropeptide Y or proopiomelanocortin mRNA expression, and insulin-treated animals did not become insulinresistant. Our results suggest that repeated iatrogenic hypoglycemia leads to weight gain, and that such weight gain is associated with a multifaceted deficit in metabolic regulation rather than to a chronic increase in caloric intake.",
keywords = "Diabetes, Hypoglycemia, Insulin, Obesity",
author = "McNay, {Ewan C.} and Teske, {Jennifer A} and Kotz, {Catherine M.} and Ambrose Dunn-Meynell and Levin, {Barry E.} and McCrimmon, {Rory J.} and Sherwin, {Robert S.}",
year = "2013",
month = "1",
day = "15",
doi = "10.1152/ajpendo.00262.2012",
language = "English (US)",
volume = "304",
journal = "American Journal of Physiology",
issn = "0363-6143",
publisher = "American Physiological Society",
number = "2",

}

TY - JOUR

T1 - Long-term, intermittent, insulin-induced hypoglycemia produces marked obesity without hyperphagia or insulin resistance

T2 - A model for weight gain with intensive insulin therapy

AU - McNay, Ewan C.

AU - Teske, Jennifer A

AU - Kotz, Catherine M.

AU - Dunn-Meynell, Ambrose

AU - Levin, Barry E.

AU - McCrimmon, Rory J.

AU - Sherwin, Robert S.

PY - 2013/1/15

Y1 - 2013/1/15

N2 - A major side effect of insulin treatment of diabetes is weight gain, which limits patient compliance and may pose additional health risks. Although the mechanisms responsible for this weight gain are poorly understood, it has been suggested that there may be a link to the incidence of recurrent episodes of hypoglycemia. Here we present a rodent model of marked weight gain associated with weekly insulin-induced hypoglycemic episodes in the absence of diabetes. Insulin treatment caused a significant increase in both body weight and fat mass, accompanied by reduced motor activity, lowered thermogenesis in response to a cold challenge, and reduced brown fat uncoupling protein mRNA. However, there was no effect of insulin treatment on total food intake nor on hypothalamic neuropeptide Y or proopiomelanocortin mRNA expression, and insulin-treated animals did not become insulinresistant. Our results suggest that repeated iatrogenic hypoglycemia leads to weight gain, and that such weight gain is associated with a multifaceted deficit in metabolic regulation rather than to a chronic increase in caloric intake.

AB - A major side effect of insulin treatment of diabetes is weight gain, which limits patient compliance and may pose additional health risks. Although the mechanisms responsible for this weight gain are poorly understood, it has been suggested that there may be a link to the incidence of recurrent episodes of hypoglycemia. Here we present a rodent model of marked weight gain associated with weekly insulin-induced hypoglycemic episodes in the absence of diabetes. Insulin treatment caused a significant increase in both body weight and fat mass, accompanied by reduced motor activity, lowered thermogenesis in response to a cold challenge, and reduced brown fat uncoupling protein mRNA. However, there was no effect of insulin treatment on total food intake nor on hypothalamic neuropeptide Y or proopiomelanocortin mRNA expression, and insulin-treated animals did not become insulinresistant. Our results suggest that repeated iatrogenic hypoglycemia leads to weight gain, and that such weight gain is associated with a multifaceted deficit in metabolic regulation rather than to a chronic increase in caloric intake.

KW - Diabetes

KW - Hypoglycemia

KW - Insulin

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=84872400886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872400886&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00262.2012

DO - 10.1152/ajpendo.00262.2012

M3 - Article

C2 - 23169787

AN - SCOPUS:84872400886

VL - 304

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6143

IS - 2

ER -